英文别名:
LLY-283;2-(4-Aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-[hydroxy(phenyl)methyl]oxolane-3,4-diol;CCG-267947;AKOS040741962;7-[(5R)-5-C-phenyl-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;s8883;EX-A4936;LLY-283, >=98% (HPLC);(2R,3R,4S,5R)-2-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-((R)-hydroxy(phenyl)methyl)tetrahydrofuran-3,4-diol;(2R,3R,4S,5R)-2-{4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol;2040291-27-6;BL166665;(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol;LLY 283;LLY-283?;s8479;HY-107777;(2R,3R,4S,5R)-2-{4-aminopyrrolo[2,3-d]pyrimidin-7-yl}-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol;CHEMBL4168754;DA-65024;CS-0030144;BDBM50366992;SCHEMBL18205034;F5J;(2R,3R,4S,5R)-2-(4-aminopyrrolo(2,3-d)pyrimidin-7-yl)-5-((R)-hydroxy(phenyl)methyl)oxolane-3,4-diol;MS-25239;AC-36692;C92219;GTPL9527;(R)-5′-phenyl-7-deazaadenosine; 6-amino-9-[(R)-5′-phenyl(ribofuranosyl)]-7-deazapurine;LLY283;
Inchi:
1S/C17H18N4O4/c18-15-10-6-7-21(16(10)20-8-19-15)17-13(24)12(23)14(25-17)11(22)9-4-2-1-3-5-9/h1-8,11-14,17,22-24H,(H2,18,19,20)/t11-,12+,13-,14-,17-/m1/s1